These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33087754)

  • 1. The effect of proteolytic enzymes and pH on GII.4 norovirus, during both interactions and non-interaction with Histo-Blood Group Antigens.
    Chassaing M; Robin M; Loutreul J; Majou D; Belliot G; de Rougemont A; Boudaud N; Gantzer C
    Sci Rep; 2020 Oct; 10(1):17926. PubMed ID: 33087754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric GII.3/GII.6 norovirus capsid (VP1) proteins: characterization by electron microscopy, trypsin sensitivity and binding to histo-blood group antigens.
    Ma S; Zheng L; Liu J; Wang W; Ma J; Cheng X; Ge L; Wang M; Huo Y; Shen S
    Arch Virol; 2018 Dec; 163(12):3265-3273. PubMed ID: 30143876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic cleavage promotes disassembly of GII.3 norovirus virus like particles and its binding to salivary histo-blood group antigens.
    Huo Y; Wang W; Zheng L; Chen X; Shen S; Wang M
    Virus Res; 2017 Aug; 240():18-24. PubMed ID: 28754559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
    Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
    Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear epitope binding antibodies against GII.3 Norovirus exhibit no histo-blood group antigens (HBGAs) blocking effects.
    Ma S; Zhang F; Zheng L; Liu J; Ma J; Chen X; Yang Z; Wang W; Li L; Wang M; Huo Y
    Virus Genes; 2019 Jun; 55(3):280-289. PubMed ID: 30725444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of natural ageing and heat treatments on GII.4 norovirus binding to Histo-Blood Group Antigens.
    Robin M; Chassaing M; Loutreul J; de Rougemont A; Belliot G; Majou D; Gantzer C; Boudaud N
    Sci Rep; 2019 Oct; 9(1):15312. PubMed ID: 31653918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and characterization of the major capsid protein derived from a GII.6 norovirus strain isolated in China.
    Huo Y; Zheng L; Chen X; Ge L; Wang Y
    Microb Pathog; 2017 Apr; 105():131-137. PubMed ID: 28219831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human norovirus inhibition by a human milk oligosaccharide.
    Koromyslova A; Tripathi S; Morozov V; Schroten H; Hansman GS
    Virology; 2017 Aug; 508():81-89. PubMed ID: 28505592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between norovirus and Histo-Blood Group Antigens: A key to understanding virus transmission and inactivation through treatments?
    Chassaing M; Boudaud N; Belliot G; Estienney M; Majou D; de Rougemont A; Gantzer C
    Food Microbiol; 2020 Dec; 92():103594. PubMed ID: 32950136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The attachment factors and attachment receptors of human noroviruses.
    Zhan X; Li Q; Tian P; Wang D
    Food Microbiol; 2024 Oct; 123():104591. PubMed ID: 39038896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and immunological characterization of major capsid protein VP1 from distinct GII.2 norovirus clusters.
    Ma J; Liu J; Huo Y
    Sci Rep; 2024 Sep; 14(1):21035. PubMed ID: 39251865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free Chlorine and Peroxynitrite Alter the Capsid Structure of Human Norovirus GII.4 and Its Capacity to Bind Histo-Blood Group Antigens.
    Chassaing M; Bastin G; Robin M; Majou D; Belliot G; de Rougemont A; Boudaud N; Gantzer C
    Front Microbiol; 2021; 12():662764. PubMed ID: 33927710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of virus-like particles derived from a GII.3 norovirus strain distantly related with current dominating strains.
    Huo Y; Chen X; Zheng L; Huo J; Zhang S; Wang M; Wang Y
    Virus Genes; 2016 Oct; 52(5):613-9. PubMed ID: 27234312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Norovirus Binding Patterns in Nonsecretor Individuals.
    Tarris G; Estienney M; Daval-Frérot P; Lariotte AC; Aubignat D; Sé K; Michiels C; Martin L; de Rougemont A; Belliot G
    J Virol; 2022 Oct; 96(19):e0086522. PubMed ID: 36121297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of host ligand specificity change of GII porcine noroviruses from their closely related GII human noroviruses.
    Yang Y; Xia M; Wang L; Arumugam S; Wang Y; Ou X; Wang C; Jiang X; Tan M; Chen Y; Li X
    Emerg Microbes Infect; 2019; 8(1):1642-1657. PubMed ID: 31711377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a broad-spectrum therapeutic Fc-nanobody for human noroviruses.
    Hansman GS; Kher G; Svirina AD; Tame JRH; Hartley-Tassell L; Irie H; Haselhorst T; von Itzstein M; Rudd PA; Pancera M
    J Virol; 2024 Jul; 98(7):e0070724. PubMed ID: 38953655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor profile and immunogenicity of the non-epidemic norovirus GII.8 variant.
    Gao J; Xue L; Liang Y; Wang L; He F; Meng L; Cai W; Zhang J; Wang J; Ye Q; Wu S; Gu Q; Wu Q
    Virus Res; 2021 Dec; 306():198603. PubMed ID: 34662679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.
    Yang Y; Xia M; Tan M; Huang P; Zhong W; Pang XL; Lee BE; Meller J; Wang T; Jiang X
    J Virol; 2010 Sep; 84(18):9595-607. PubMed ID: 20592096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability.
    Hansman GS; Biertümpfel C; Georgiev I; McLellan JS; Chen L; Zhou T; Katayama K; Kwong PD
    J Virol; 2011 Jul; 85(13):6687-701. PubMed ID: 21525337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GII.13/21 Noroviruses Recognize Glycans with a Terminal β-Galactose via an Unconventional Glycan Binding Site.
    Cong X; Sun XM; Qi JX; Li HB; Chai WG; Zhang Q; Wang H; Kong XY; Song J; Pang LL; Jin M; Li DD; Tan M; Duan ZJ
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31118252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.